Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in La Source Orleans

4 clinical trials in La Source Orleans, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
La Source Orleans at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in La Source Orleans

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Centre Hospitalier De Versailles
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:The University Of Birmingham
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Atezolizumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in La Source Orleans

What the registry says about research in the country

01 Lung Cancer Research

Innovative clinical trials focusing on Non-Small-Cell Lung Cancer treatment in elderly patients, combining immunotherapy with traditional chemotherapy approaches.

  • Advanced NSCLC Treatment
  • Elderly Patient Care
  • Immunotherapy Applications

Research evaluating the effectiveness of combining atezolizumab with established chemotherapy protocols to improve survival rates.

02 Blood Disorders

Comprehensive studies on Polycythemia Vera, examining new therapeutic approaches for high-risk patients through comparative treatment analysis.

  • Thrombosis Prevention
  • Disease Transformation
  • Treatment Optimization

Evaluation of ruxolitinib against standard therapies, focusing on preventing major complications and disease progression.

03 Leukemia Studies

Advanced research into Chronic Myelogenous Leukemia, investigating combination therapies with tyrosine kinase inhibitors.

  • Molecular Response
  • Treatment Combinations
  • Disease Management

Testing innovative therapeutic combinations to achieve deeper molecular responses in patients with CP-CML.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.